MARC Record from marc_columbia

LEADER: 05657fam a2200457 a 4500
001 4044584
005 20221027023735.0
008 940421t19941994nyua b 001 0 eng c
010 $a 94012397
020 $a0781701430
035 $a(OCoLC)30437188
035 $a(OCoLC)ocm30437188
035 $9AKD3641HS
035 $a(NNC)4044584
035 $a4044584
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC483$b.C5355 1994
060 10 $aWM 402 1994
082 00 $a616.89/18$220
245 00 $aClinical evaluation of psychotropic drugs :$bprinciples and guidelines /$cin association with the NIMH and the ACNP ; editors, Robert F. Prien, Donald S. Robinson ; section editors, C. James Klett [and others].
260 $aNew York :$bRaven Press,$c[1994], ©1994.
300 $axxi, 728 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 0 $a1. History and Role of Guidelines and Guidance for Drug Evaluation / Jerome Levine -- 2. Decision Processes in Establishing the Efficacy and Safety of Psychotropic Agents / Louis Lasagna -- 3. Design Issues for the Clinical Evaluation of Psychotropic Drugs / Eugene M. Laska, Donald F. Klein, Philip W. Lavori, Jerome Levine and Donald S. Robinson -- 4. Classification Issues in Patient Selection and Description / Jean Endicott, Gerri E. Schwartz, J. Hillary Lee and Harold Pincus -- 5. Assessment and Measurement of Clinical Change / A. John Rush, Christina M. Gullion, Allen Raskin, Robert Kellner and John J. Bartko -- 6. Pharmacologic Considerations / David J. Greenblatt, Darrell R. Abernethy and Philip Chaikin -- 7. Statistical Issues for the Clinical Evaluation of Psychotropic Drugs / Philip W. Lavori, Eugene M. Laska and E. H. Uhlenhuth -- 8. Clinical Trial Implementation / Ronald Kartzinel, Alan B. Lisook, Barbara Rullo, Joanne B. Severe and Bert Spilker.
505 8 $a9. Premarketing Safety Evaluation of Psychotropic Drugs / Thomas P. Laughren, Jerome Levine, Jonathan G. Levine and W. Leigh Thompson -- 10. Post-Marketing Surveillance of Drugs / Leo E. Hollister, Judith K. Jones and Seymour Fisher -- 11. Documenting and Reporting the Study Results of a Randomized Clinical Trial (Spicy Meatballs, Not Pabulum) / David J. Kupfer, Helena C. Kraemer and John J. Bartko -- 12. Ethical and Legal Considerations in Drug Trials / Don Gallant and Susan L. Krinsky -- 13. Evaluating Drug Treatments of Depressive Disorders / Gerald L. Klerman, Myrna M. Weissman, Ellen Frank, James H. Kocsis, John C. Markowitz and Stuart Montgomery -- 14. Evaluating Pharmacologic Treatments for Bipolar Disorder / Alan J. Gelenberg, Ellen Frank, Martin B. Keller, Robert F. Prien and Robert M. Post -- 15. Methods for Clinical Evaluation of Pharmacologic Treatments of Schizophrenia / John M. Kane, Nina R. Schooler, Stephen R. Marder, George M. Simpson and Daniel E. Casey.
505 8 $a16. Evaluating Drug Treatments of Generalized Anxiety Disorder and Adjustment Disorders with Anxious Mood / Kari Rickels, Russell Noyes, Jr., Donald S. Robinson, Edward Schweizer and E. H. Uhlenhuth -- 17. Evaluation of Psychotropic Drug Treatment of Panic-Related Disorders and Social Phobia / Donald F. Klein, Michael R. Liebowitz, Jack M. Gorman and Carl P. Lewis -- 18. Obsessive-Compulsive Disorder / Wayne K. Goodman, Steven A. Rasmussen, Edna B. Foa and Lawrence H. Price -- 19. Methods for the Evaluation of Pharmacologic Agents in the Treatment of Cognitive and Other Deficits in Dementia / Samuel Gershon, Steven H. Ferris, John S. Kennedy, Neil M. Kurtz, John E. Overall, Bruce G. Pollock, Barry Reisberg and Peter J. Whitehouse -- 20. Clinical Trials in Children and Adolescents / Rachel G. Klein, Howard Abikoff, Russell A. Barkley, Magda Campbell, James F. Leckman, Neal D. Ryan, Mary V. Solanto and Carol K. Whalen.
505 8 $a21. Evaluation of Pharmacologic Treatments in Eating Disorders / Katherine A. Halmi, W. Stewart Agras, Walter H. Kaye and B. Timothy Walsh -- 22. Evaluation of Hypnotic Medications / Thomas Roth, Timothy A. Roehrs, Gerald W. Vogel and William C. Dement -- 23. Establishing the Efficacy and Safety of Medications for the Treatment of Drug Dependence and Abuse: Methodologic Issues / Jack D. Blaine, Walter Ling, Thomas R. Kosten, Charles P. O'Brien and Robert J. Chiarelio -- 24. Evaluation of Pharmacologic Treatments for Alcohol Abuse, Dependence, and Their Complications / Markku Linnoila, Jan Fawcett, Richard K. Fuller, Thomas C. Harford, Peter B. Martin, Roger E. Meyer, Myroslava K. Romach and Edward M. Sellers -- 25. Evaluation of Pharmacologic Treatments in Personality Disorders / Paul H. Soloff, Larry Siever, Rex Cowdry and James H. Kocsis.
650 0 $aPsychotropic drugs$xTesting.
650 0 $aMental illness$xChemotherapy$xEvaluation.
650 0 $aMental illness$xChemotherapy$xResearch.
650 2 $aMental Disorders$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D001523Q000188
650 2 $aDrug Evaluation$xmethods.$0https://id.nlm.nih.gov/mesh/D004341Q000379
650 2 $aPsychotropic Drugs.$0https://id.nlm.nih.gov/mesh/D011619
650 2 $aClinical Trials as Topic.$0https://id.nlm.nih.gov/mesh/D002986
700 1 $aPrien, Robert F.$0http://id.loc.gov/authorities/names/n82225717
700 1 $aRobinson, Donald S.$0http://id.loc.gov/authorities/names/n81054410
710 2 $aNational Institute of Mental Health (U.S.)$0http://id.loc.gov/authorities/names/n79041811
710 2 $aAmerican College of Neuropsychopharmacology.$0http://id.loc.gov/authorities/names/n79076064
852 00 $boff,hsl$hRC483$i.C5355 1994